Gastric MALT lymphomas are clinically and histologically quite distinct from comparable low-grade B-cell lymphomas of lymph nodes. Their histology suggests that immunological mechanisms might be operative in their growth. Given that there is normally no lymphoid tissue in gastric mucosa and that Helicobacterpvlori (H pylori), the only common bacterial antigen in the stomach, results in the accumulation of gastric MALT, the possibility that this organism is implicated in the pathogenesis of gastric lymphoma has been extensively investigated. It appears that most, but not necessarily all, gastric MALT lymphomas arise in MALT acquired in response to H. pylori infection and develop by stepwise accumulation of genetic abnormalities. Early molecular events in the evolution of gastric MALT lymphoma from 'acquired' MALT include trisomy 3, t(l I;18)(q21;q21), genetic damage leading to genetic instability, as indicated by the so-called replication error repair (RER) phenotype, and both/?5J and c-myc mutations. At this stage in their development, the growth of the lymphomas is driven by contact between the neoplastic B cells and H. pylori specific intra-tumoral T cells. Eradication of H. pylori causes the tumour to enter a latent phase resulting in clinical regression. Later events, such as t(l;14)(p22;q32), appear to be linked to a capacity for autonomous growth, loss of sensitivity to H. pylori and dissemination of the lymphoma beyond the stomach and gastric lymph nodes. Cloning of the breakpoint in t(l;14) has allowed the identification of a new tumour suppresser gene, bcllO. High grade transformation of MALT lymphoma has been associated with p53 inactivation, deletions of>;<5andt(8;14).
Introduction
The seminal observations of Lennert [1] and Lukes and Collins [2] in the late 1970s that most non-Hodgkin's lymphomas recapitulate the morphological and functional properties of normal lymph nodes had a profound effect on the clinicopathological approach to non-Hodgkin's lymphomas. However, in the excitement generated by this work, the fact that up to a third of lymphomas arise in extranodal lymphoid tissue was overlooked, the assumption at that time being that the lymph node was the paradigm for all lymphoid tissue. That this was clearly not the case was contemporaneously being shown by a number of mucosal immunologists who were busy defining the distinctive properties of mucosa associated lymphoid tissue (MALT) [3] .
The suggestion that the histology and clinical behaviour of certain extranodal lymphomas was related to MALT rather than nodal lymphoid tissue was first made by Isaacson and Wright in 1983 [4] . These authors noted an intriguing similarity between the clinical and histological features of immunoproliferative small intestinal disease (IPSID), a peculiar variant of primary intestinal B-cell lymphoma, and primary low-grade gastric B-cell lymphoma. Clinically, both showed a tendency to remain localised for long periods, which distinguished them from their nodal counterparts. There were also subtle histological differences between these primary gastrointestinal tumours and comparable low-grade nodal B-cell lymphomas in that their structure and cytology resembled those of MALT rather than lymph nodes. Isaacson and Wright soon extended these observations to include a number of other extranodal low grade B-cell lymphomas including those of the salivary gland, lung and thyroid [5] . They rationalised that the tendency of these lymphomas to remain localised was in keeping with the specific circulation pathways and homing properties of MALT, from which they arose. Later they showed that their histology closely recapitulated the features of the principal B-cell component of MALT, namely the Peyer's patch [6, 7] . MALT lymphomas, now classified as extranodal marginal zone lymphomas of MALT-type (see below) arise in numerous extranodal sites that are summarised in Table 1 . Gastric MALT lymphoma is by far the commonest and because of this and its accessibility it has been most extensively studied and is, therefore, the archetype of the group as a whole.
Clinical presentation
Gastric MALT lymphoma occurs over a wide age range with a median of 57 years. The sex incidence is equal [8] . The symptoms are usually those of uncomplicated dyspepsia sometimes with evidence of chronic blood loss. The endoscopic findings vary from a single large ulcer to a flat gastritic appearance sometimes accompanied by many superficial ulcers. In the majority of cases the endoscopic diagnosis is one of a non-neoplastic inflammatory process. Most patients have stage IE disease at diagnosis but up to 10%-20% may be at stage HE and a further 5%-10% have bone marrow involvement [9, 10] .
Pathology
Gastric lymphoma, like carcinoma, most often involves the antrum but may occur in any part of the stomach. The histological features of low-grade gastric MALT lymphoma closely simulate those of the Peyer's patch [11, 12] . The lymphoma infiltrates around reactive follicles in the region corresponding to the Peyer's patch marginal zone, spreading diffusely into the surrounding mucosa. The tumour cells may resemble follicle centre centrocytes (centrocyte-like cells), small lymphocytes or so-called monocytoid B cells. Scattered transformed blasts are common and may cause problems in grading the lymphoma (see below). An important feature of MALT lymphomas is the presence of lymphoepithelial lesions formed by invasion of individual glands by aggregates of lymphoma cells. Certain additional histological features suggest that the cells of low-grade gastric MALT lymphoma may be participating in an immune response. These include the presence of scattered transformed blasts, plasma cell differentiation, which is maximal beneath the surface epithelium, and follicular colonisation [13] .
Immunophenotype and normal cell counterpart
MALT lymphoma cells typically surround reactive B-cell follicles in the distribution of the marginal zone and show a tendency to involve this zone when they disseminate to lymph nodes and spleen (see below). The B cells of MALT lymphoma share the cytological features and immunophenotype (CD20+, CD21+, CD35+, IgM+, IgD-) of marginal zone B cells [7] . Thus, in the Revised European-American Lymphoma (R.E.A.L.) Classification [14] the full designation of this lymphoma is given as marginal zone B-cell lymphoma of MALTtype.
Dissemination
Recent studies suggest that gastric MALT lymphoma disseminates both locally and systemically more frequently than was originally believed. Indirect evidence for this comes from the observation of recurrent MALT lymphomas in the gastric stump after partial gastrectomy in patients in whom clear resection margins were documented by histological examination [15, 16] . Wotherspoon et al. [17] systematically examined gastrectomy specimens of five low-grade gastric MALT lymphomas using a 'Swiss roll' technique. They showed that numerous small tumour foci with identical immunoglobulin (Ig) light chain restriction to the main tumour mass were distributed throughout the gastric mucosa including macroscopically normal regions. A subsequent investigation by sequence analysis of the rearranged Ig heavy chain genes confirmed the clonal identity of these multiple tumour foci [18] . Further study by microdissection and clone specific PCR demonstrated that tumour cells were frequently present in reactive lymphoid tissue that showed no histological evidence of lymphoma [19] . Intramucosal dissemination has also been well documented by Fend et al. [20] and Hoshida [21] .
Regional lymph nodes may be involved by gastric MALT lymphoma [11, 22] . This may be commoner than previously thought since the lymphoma cells tend to localise in the marginal zone without disturbing the lymph node architecture. Incidental discovery of secondary small intestinal MALT lymphoma during gastrectomy for MALT lymphoma has been reported. Du et al. [23] have studied five such cases and showed that the intestinal lesion was secondary to the gastric lymphoma. Gastric MALT lymphoma has recently been shown preferentially to disseminate to the splenic marginal zone [24] .
The propensity of gastric MALT lymphoma to disseminate to other parts of the gastrointestinal mucosa and the splenic marginal zone is thought partially to reflect the homing properties of this tumour. Dogan et al. [25] have studied a case of gastric MALT lymphoma with secondary intestinal involvement and found that the mucosal homing receptor a4b7 integrin was strongly expressed by the intestinal tumour but not by the gastric lesion. However, a high level of oc4p7 expression could be induced in gastric lymphoma cells following activation by a Helicobacter pylori (H. pylori) generated T-cell response. This suggests that a4(37+ tumour cells could be similarly generated in gastric lymphoma in vivo and thus become 'programmed' to home to an appropriate microenvironment where the mucosal addressin cell adhesion molecule (MAdCAM-1), the ligand for a4 (37, is expressed. This includes sites such as the intestinal mucosa [25, 26] and splenic marginal zone [27] .
High-grade gastric MALT lymphoma
Transformation of low to high-grade MALT lymphoma is heralded by the emergence of increased numbers of transformed blast cells which eventually form sheets or clusters [28, 29] and, finally grow to confluence effacing any trace of the preceding low grade tumour. This gives rise to practical difficulty in grading some MALT lymphomas and to theoretical difficulty in classifying large B-cell lymphomas of the stomach and other parts of the gastrointestinal tract. De Jong et al. [29] have addressed this problem and suggest dividing gastric MALT lymphoma into four categories (grades). Category A refers to classical low-grade MALT lymphoma in which transformed blasts comprise no more than 5% of cells and do not occur in clusters of more than ten cells. Certain features suggest that many cases of primary DLBCL of the stomach are mostly MALT lymphomas. These include the association of these lymphomas with H. pylori infection (see below), the absence ofbcl-2 gene rearrangement [30] which is present in 30% of high-grade nodal B-cell lymphomas and the absence of any effect of a minor low-grade component on the clinical behaviour [16, 29] .
Clinical behaviour
In comparison with nodal low-grade B-cell lymphomas, such as follicular lymphoma, which, at the time of diagnosis are characteristically at an advanced stage, low-grade MALT lymphoma is usually at stage IE or HE when diagnosed and is slow to disseminate. Hence low-grade MALT lymphoma responds favourably to therapy and there is an excellent survival of cases corresponding to De Jong et al.'s category A approximating 90% at 10 years [16, 29] [16] for their cases of high-grade gastric lymphoma with or without a low-grade MALT component. This begs the question whether there is any biological difference between gastric large B-cell lymphomas of MALT or putative non-MALT origin.
Molecular genetics

Chromosomal abnormalities
The limited availability of fresh tissue and poor in vitro growth of the tumour cells have hampered cytogenetic studies of MALT lymphoma. The results from limited studies are controversial. Using both metaphase and interphase cytogenetic techniques, Wotherspoon et al. [31] reported a number of abnormalities including t(l;14)(p22;q32) and high frequency of trisomy 3 confirmed in a later study to be present in 55% of cases [32] . This high frequency of this trisomy was observed in subsequent studies by other authors and further extended to monocytoid B-cell lymphoma, the nodal equivalent of MALT lymphoma [33, 34] . However, two recent studies, in which a relatively large series (9 and 44 cases) of MALT lymphomas were examined, failed to show the high frequency of trisomy 3 but instead revealed t(ll;18)(q21;q21) in 35% of low-grade MALT lymphomas [35, 36] . This translocation has been described in MALT lymphomas in several case studies [37] [38] [39] [40] . Interestingly, in all these cases, t(ll;18) was the sole aberration and therefore was thought to represent an early event in the genesis of MALT lymphoma. Curiously, this translocation was not observed in any of the 24 high-grade MALT lymphomas examined [36] .
Molecular genetics Replication error (RER) phenotype
This mutator phenotype is caused by a reduced efficacy of DNA mismatch repair machinery due to defects in DNA mismatch repair genes [41, 42] and is commonly determined by detection of length alterations of microsatellite loci [43, 44] . Cells with the RER+ phenotype are highly prone to accumulation of somatic mutations and thus at high risk of malignant transformation [45] . Peng et al. [46] examined 40 MALT lymphomas and demonstrated the RER+ phenotype in 52.5% cases, with a slightly higher frequency in high-grade (56%) than in low-grade (50%) tumours. High-grade MALT lymphomas always harboured a greater number and more heterogeneous microsatellite alterations than low-grade tumours. Similar results were reported by Chong et al. [47] but not by Xu et al. [48] . The findings of Peng et al. suggest that microsatellite alterations are an ongoing event in gastric MALT lymphoma. This is also indirectly supported by the significant association of RER+ phenotype with p53 mutations [46] . Thus, the RER+ phenotype observed in gastric MALT lymphoma is likely to be a true tumourgenesis associated phenomenon rather than a reflection of the heterogeneous nature of the normal cell population [49] . This genetic instability may contribute to the accumulation of genetic abnormalities during the evolution of gastric MALT lymphoma and also explain the increased incidence of additional solid tumours observed in patients with this malignancy in southern Switzerland and northern Italy [50] and in other gastric lymphoma series [51, 52] .
p53 abnormalities Loss ofp53 function is commonly caused by mutation in one allele and loss of the other and is the most common genetic defect found in human cancer, contributing to both early tumour development and subsequent disease progression [53, 54] . In low-grade MALT lymphoma, p53 allele loss and mutation were found in 6.8% and 18.8% cases, respectively, with concomitant p53 mutation and allelic loss being rare (1 of 11 affected cases) [55] . This indicates that p53 function is only partly inactivated. High-grade MALT lymphomas showed more frequent p53 allele loss (28.6%) and mutation (33.3%) than lowgrade lesions. More importantly, the majority of affected high-grade cases (six of nine) showed both p53 allele loss and mutation, indicating completep53 inactivation.
c-myc abnormalities
In low-grade MALT lymphoma, neither cytogenetic nor Southern blot studies have shown c-myc translocation or rearrangement [31, 34, 56] . However, somatic mutation of the regulatory regions of the c-myc gene was found in 16% of low-grade and 18% of high-grade MALT lymphomas by sequence analysis [57] . The significance of these mutations in MALT lymphomagenesis remains to be determined. Translocation involving c-myc [t(8;14)(q24;q32)] has been reported 3 of 24 cases highgrade MALT lymphoma [36] . pl6 Inactivation of the pl6 gene, one of the major negative regulators at the early Gl phase of the ceil cycle, has been found in a wide variety of human tumours. In lymphoid malignancies, pl6 deletion has been almost exclusively found in high-grade tumours [58, 59] . Neumeister et al. [60] examined 28 low-grade and 14 high-grade gastric MALT lymphomas and showed homozygous deletion of pl6 in 2 high-grade cases, suggesting a role forpl6 deletion in high-grade transformation in some cases.
Following the original description by Wotherspoon et al. of t(l; 14)(p22;q32) in a MALT lymphoma of the lung and inv(l)(p22p36) in a case of gastric MALT lymphoma [31] . t(l;14)(p22;q32) was found in a second case of gastric lymphoma (unpublished observations). Both these cases of gastric MALT lymphoma with a Ip22 breakpoint showed unusually aggressive clinical and/or histological features. Moreover, cell culture experiments [61] showed that the lymphomas with t(l;14)(p22;q32) were capable of independent growth in contrast to other low-grade MALT lymphomas which would grow in culture only in the presence of both antiIg and mitogens. Recently Willis et al. [62] have cloned the breakpoint involved in this translocation and showed that it occurs upstream of the promoter region of a novel gene which they designated bcl-\0. Transfection experiments showed that the wild type bcl-\0 gene is pro-apoptotic and suppresses transformation but the mutated gene cloned from the gastric lymphoma not only failed to induce apoptosis but also enhanced transformation by co-operating oncogenes. Preliminary analyses suggest that bcl-10 mutations are present in some gastric MALT lymphomas without t(l;14).
H. pylori and gastric lymphoma
The fact that the stomach is the commonest site of MALT lymphoma is paradoxical since the normal stomach, unlike the intestine is devoid of any organised lymphoid tissue. However, several groups [63] [64] [65] have shown that infection of the stomach by H. pylori leads to the accumulation of lymphoid tissue in the gastric mucosa within which B-cell follicles are characteristically present; indeed, the presence of lymphoid follicles in the gastric mucosa is virtually pathognomonic of//, pylori infection [63] . Moreover, the acquired gastric lymphoid tissue is accompanied by a lymphoepithelium that defines it as MALT [66] . There are several lines of evidence that suggest that gastric lymphoma arises from this H. pylori associated acquired MALT. H. pylori can be demonstrated in the gastric mucosa of the majority of cases of gastric MALT lymphoma. In the first study in which this association was examined [66] the organism was present in over 90% of cases. Subsequent studies have shown a lower incidence [67] but also that the density and detectability of//, pylori decreases as lymphoma evolves from chronic gastritis [68] . Epidemiological evidence for the role of H. pylori has been provided by a study showing that in at least one geographic area, the Veneto region of Italy, where there is a remarkably high incidence of primary gastric lymphoma, there is an accompanying high prevalence of H. pylori infection [69] and by a case control study which showed an association between previous H. pylori infection and the development of primary gastric lymphoma [70] . More direct evidence confirming the importance of H. pylori in the pathogenesis of gastric lymphoma has been obtained from a series of in vitro studies [71] together with clinical evaluation of the effect of eradicating the organism in cases of low-grade gastric lymphoma [72] .
Response of cells of low-grade gastric MALT lymphoma to H. pylori
Initial experiments attempting to show direct antigenic stimulation of MALT lymphoma B cells by H. pylori were unsuccessful. Later experiments showed that while unsorted cells from cases of low-grade primary B-cell gastric lymphoma cultured under standard conditions characteristically die in the first five days, the addition of heat killed whole cell preparations of H. pylori resulted in clustering and proliferation of tumour cells [71] . This reaction was specific for the particular strain of//, pylori used and was associated with expression of IL-2 receptors and release of tumour cell derived Ig and IL-2 into the supernatant. Control cells derived from nodal lowgrade lymphomas did not respond to any strains of H. pylori. The removal of T cells from cell suspensions of gastric lymphomas before initiating the cultures abrogated all indices of activation induced by the inclusion of H. pylori. Further experiments showed that the T-cell stimulation depended on direct T-B-cell interaction via CD40-mediated signalling [73, 74] and that only the intratumoral T cells were H. pylori specific in contrast toT cells obtained from non-gastric tissue from the same patient [73] . These immunological findings may at least partly explain why gastric MALT lymphomas tend to remain localised to the stomach since their growth is dependent on H. pylori specific activated T cells, which, while present in abundance in H. pylori gastritis, are unlikely to be present outside the gastric environment. In those low-grade gastric MALT lymphomas that have disseminated beyond the gastric environment some further molecular event must have occurred resulting the ability to grow which no longer requires help from H. pylori specific T cells.
Several histological features of low-grade MALT lymphoma, such as the intimate interaction of tumour cells with reactive follicles (follicular colonisation) and its association with active tumour cell proliferation and blast transformation [13] , suggest that the tumour cells may receive antigen stimulation via antigen receptors. Although attempts to show this in in vitro experiments failed, cross-linking surface Ig on tumour cells in some low-grade MALT lymphomas stimulated tumour cell proliferation [74, 75] . These experiments suggested that direct antigen stimulation of tumour cells was a factor in MALT lymphoma and this was further supported by immunohistochemical studies. These showed that idiotypic Ig prepared from gastric MALT lymphoma B cells reacted with a variety of auto-antigens including, in one case, rheumatoid factor [76] . This notion has been reinforced by the analysis of gastric MALT lymphoma Ig genes which showed that they were frequently derived from germline genes commonly used for autoantibodies [77] . Further genetic analyses demonstrated the presence of somatic mutations of tumour derived Ig genes with evidence of intraclonal sequence variations i.e., ongoing mutations in the majority of cases [77] [78] [79] . As somatic mutations occur at the Ig locus specifically in B cells engaging in the germinal centre reaction, an antigen driven immune response [80] , the finding of ongoing mutations strongly suggests that direct antigen stimulation plays a role in the clonal expansion of this tumour. This is supported by genetic evidence that evolution of the tumour clone is constantly under a positive or negative selection pressure [24, 77, 81] . There are some preliminary data suggesting that the rate of ongoing mutations gradually declines during the evolution from an early to a late stage of low-grade tumour and that finally the activity disappears in high-grade lesions [24, 76] . Thus, it is likely that the role of direct antigen stimulation in the pathogenesis of this tumour progressively decreases during tumour evolution.
Regression of low-grade gastric MALT lymphomas following eradication of H. pylori
In the light of the evidence that the growth of low-grade gastric MALT lymphoma is influenced by antigen, and the more substantive experimental evidence summarised above, an attempt was made to evaluate the effect of eradicating H. pylori in clinical cases of gastric MALT lymphoma [72] . Six patients (three females and three males) in whom primary low-grade gastric MALT lymphoma and H. pylori infection had been diagnosed following endoscopic biopsy were selected for the study. In five of the six, molecular analysis using the polymerase chain reaction (PCR) had confirmed a monoclonal B-cell population in the lesion. In all patients the lymphoma had not given rise to an identifiable tumour mass and was, thus, thought to represent early disease. Following the diagnostic biopsy the patients received appropriate antibiotics for eradication of H. pylori. Repeat post-treatment biopsies were performed at regular intervals and each biopsy evaluated for the histological changes of lymphoma, the presence of H. pylori and for any molecular evidence of a monoclonal B-cell population. In all six patients, H. pylori were successfully eradicated and complete remission of the lymphoma was achieved as judged on endoscopic, histological and molecular grounds. Studies on further cases [82] have shown similar results except that in some cases molecular evidence of the presence of monoclonal tumour cells has persisted in the absence of any histological evidence of disease. Several independent groups have now confirmed that eradication of H. pylori may induce remission in cases of low-grade B-cell lymphoma of the stomach [83] [84] [85] [86] . These studies have given rise to a number of important questions. These relate to the use of PCR to demonstrate of Ig gene rearrangement as an aid to the diagnosis of MALT lymphoma, the likely duration of regression following antibiotics, the effect of histological grade and tumour bulk, or depth of invasion, the interval between eradication of H. pylori and regression of the lymphoma and, finally, the effect of relapse of the H. pylori infection.
PCR detection of Ig gene rearrangement in gastric MALT lymphoma
Because of the difficulty in assessing gastric biopsies both before and after eradication of H. pylori there has been a tendency to rely on molecular evidence of monoclonality detected by the polymerase chain reaction p53 inactivation p i 6 deletion 1 (8, 14) HG MALT Lymphoma Figure 1 The pathogenesis of gastric MALT lymphoma.
(PCR) for the diagnosis of lymphoma both before and after antibiotic therapy for H. pylori. This technique may fail to detect monoclonality in up to 30% of cases of overt lymphoma and thus produce false negative results [87] . Of more concern are reports of apparently spurious monoclonality in biopsies showing only chronic gastritis [88] [89] [90] and in biopsies following antibiotic induced regression of lymphoma where there is no histological evidence of malignancy [82] . The frequency of this spurious monoclonality varies considerably between laboratories [91] , which suggests that technique may be a factor. However, two recent studies have shown that the emergence of a monoclonal B-cell population in H. pylori associated chronic gastritis may precede histological evidence of lymphoma by several years [68, 92] . Moreover, transient monoclonality may characterise uncomplicated chronic gastritis [92] . The persistence of monoclonality in post-treatment biopsies without evidence of lymphoma is consistent with the notion that eradication of H. pylori suppresses but does not necessarily eradicate the neoplastic lone in all cases. These findings serve to emphasise that gastric MALT lymphoma should not be diagnosed in the absence of clear histological evidence. 
Relapse of H. pylori infection
The relapse rate following successful eradication of H. pylori is approximately 1.5%. True recurrent infections with a new strain of the organism are extremely rare. Relapses of infection may be accompanied by recurrence of lymphoma [94] highlighting yet again the suppressive rather than ablative effect of antibiotic therapy.
Practical considerations in the use of antibiotics for treatment of gastric MALT lymphoma
When contemplating using antibiotics to treat gastric MALT lymphoma it is imperative that the presence of H. pylori infection be unequivocally established by histology, breath test or serology since a minority of cases of gastric MALT lymphoma is H. pylori negative. This should be followed by careful assessment of the histological grade and by both endosonographic and conventional staging. Although eradication of the organism is indicated in all cases, complete remission with antibiotics alone can be anticipated only in those of appropriate stage and grade.
The pathogenesis of gastric MALT lymphoma
The evolution of gastric MALT lymphoma is a multistage process, which comprises sequential development of chronic H. pylori associated gastritis, low-grade and high-grade tumour. On the basis of the observations summarised above, a tentative scheme for the pathogenesis of this tumour is illustrated in Figure 1 . This scheme suggests that the lymphoma cells gradually accumulate genetic abnormalities and gain the ability for autonomous growth while gradually losing dependence on immunological stimulation during tumour evolution.
As a result of//, pylori infection, B and T cells together with neutrophils, the primary effector cells in the host defence, are recruited to the gastric mucosa and form MALT. The host immune response to H. pylori induces and sustains an actively proliferating B-cell population, which is constantly subject to genotoxic insult by activation of neutrophils. In rare cases, during the course of this chronic inflammatory disease, the RER+ phenotype and genetic abnormalities such as t(ll;18), trisomy three and both p53 and c-myc mutation may develop in B cells, particularly in those which recognise autoantigen and already possess a growth advantage. These events may lead to the outgrowth of a transformed B-cell clone. In the presence of growth help from H. pylori specific T cells, this abnormal B-cell clone may expand to form a frank low-grade MALT lymphoma. At this stage, the tumour is most frequently confined to the stomach and will regress following eradication of//, pylori. Current evidence suggests that lymphomas that respond in this way enter a latent phase with persistence of the neoplastic clone which can be re-activated by re-infection with H. pylori or by other as yet understood mechanisms. Additional genetic abnormalities result in escape from T-cell dependency increased aggressiveness on the part of the lymphoma manifested by deep invasion and/or systemic dissemina-: on. These events are currently poorly understood but abnormality of the newly described bcl-\0 gene (see above) is one possible candidate. Finally, further genetic events including complete inactivation of the tumour suppresser genes p53 and pl6, and, possibly, activation of c-myc oncogene by translocation and other undetermined abnormalities can result in high-grade transformation.
Summary and conclusions
Gastric MALT lymphomas are clinically and histologically quite distinct from comparable low-grade B-cell lymphomas of lymph nodes. Their histology suggests that immunological mechanisms might be operative in their growth. Given that there is normally no lymphoid tissue in gastric mucosa and that H. pylori, the only common bacterial antigen in the stomach, results in the accumulation of gastric MALT, the possibility that this organism is implicated in the pathogenesis of gastric lymphoma has been extensively investigated. It appears that most, but not necessarily all, gastric MALT lymphomas arise in MALT acquired in response to H. pylori infection and develop by stepwise accumulation of genetic abnormalities. Early in their development, the growth of the lymphomas is driven by contact between the neoplastic B cells and H. pylori specific intra-tumoral T cells. Eradication of H. pylori causes the tumour to enter a latent phase resulting in clinical regression. This response does not occur in lymphomas that have progressed following the accumulation of further genetic abnormalities.
Formulation of the MALT lymphoma concept was one of the factors that led to an appreciation of relative shortcomings of contemporary classifications of nonHodgkin's lymphomas. This led to a re-evaluation of lymphoma classification by members the International Lymphoma Study Group who then went on to propose a classification based on defined disease entities rather than more abstract concepts [95] . Applying these new concepts, the Lymphoma Classification Project [96] has established that MALT-type lymphomas, far from being a rare oddity, as a group comprise the third commonest non-Hodgkin's lymphoma. Studies of gastric MALT lymphoma have served to emphasise that lymphomas comprise dynamic cell populations that are, at least to a degree, subject to physiological immunological control and that this offers avenues towards new therapies.
